| 产品描述: | MAP4K 抑制剂;MAP4K Inhibitors;;InformationPF-6260933 PF-6260933 (PF-06260933) is a potent inhibitor of MAP4K4 with an IC50 of 3.7 nM, possessing excellent kinome selectivity.TargetsMAP4K4 3.7 nMIn vitroPF-6260933 demonstrates good physicochemical properties as well as moderate human liver microsomal (HLM) clearance.In vivoFollowing oral dosing (10 mg/kg), PF-6260933 displays a plasma exposure that provided free drug concentrations above the cell IC50 value for about 4-6 h after administration in a mouse model. PF-6260933 has suitable PK properties in mouse to be used as a tool in an in vivo model of diabetes. |
| 体内研究: |
在小鼠模型中,PF-06260933 处理不会改变血浆脂质含量,但观察到葡萄糖水平降低,这与全身可诱导的 Map4k4 基因敲除动物一致。在此动物模型中,PF-06260933 给药可进一步改善斑块形成和/或促进斑块消退 (46.0% 对 25.5%),并且还观察到血浆葡萄糖和脂质含量降低。 |
| 参考文献: |
1. Ammirati M, et al. Discovery of an in Vivo Tool to Establish Proof-of-Concept for MAP4K4-Based Antidiabetic Treatment. ACS Med Chem Lett. 2015 Oct 6;6(11):1128-33. 2. Roth Flach RJ, et al. Endothelial protein kinase MAP4K4 promotes vascular inflammation and atherosclerosis. Nat Commun. 2015 Dec 21;6:8995. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.37 ml |
16.849 ml |
33.698 ml |
| 5 mM |
0.674 ml |
3.37 ml |
6.74 ml |
| 10 mM |
0.337 ml |
1.685 ml |
3.37 ml |
| 50 mM |
0.067 ml |
0.337 ml |
0.674 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |